These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15949258)

  • 1. [Effect of 2-methoxyestradiol on cell differentiation of myeloma cell line CZ-1].
    Gao WR; Hou J
    Zhonghua Xue Ye Xue Za Zhi; 2005 Apr; 26(4):197-9. PubMed ID: 15949258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary investigation of 2-methoxyestradiol inducing differentiation of myeloma cell line CZ-1.
    Hou J; Xiong H; Gao WR; Jiang H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):65-9. PubMed ID: 16584594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular mechanism of myeloma cell line differentiation induced by 2-methoxyestradiol].
    Gao WR; Hou J; Xiong H
    Zhonghua Xue Ye Xue Za Zhi; 2005 Oct; 26(10):598-601. PubMed ID: 16532968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of 2-methoxyestradiol on differentiation of primary myeloma cells].
    Gao WR; Hou J; Xiong H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):262-6. PubMed ID: 16638193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regulation of c-myc expression by Blimp-1 during the differentiation of myeloma cells].
    Zhou X; Zhou F; Jiang H; Hou J
    Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):318-22. PubMed ID: 17877160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Methoxyestradiol at low dose induces differentiation of myeloma cells.
    Hou J; Xiong H; Gao W; Jiang H
    Leuk Res; 2005 Sep; 29(9):1059-67. PubMed ID: 16038732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factors Xbp-1, Blimp-1, and BSAP are involved in the regulation of plasmacytic differentiation induced by 2-methoxyestradiol in myeloma cell lines.
    Jiang H; Gao W; Sze DM; Xiong H; Hou J
    Int J Hematol; 2007 Dec; 86(5):429-37. PubMed ID: 18192112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of 2-methoxyestradiol on proliferation and apoptosis of myeloma cell lines].
    Gao WR; Hou J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):293-7. PubMed ID: 15854295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordination of upregulated XBP-1 and downregulated c-myc during myeloma cell differentiation induced by 2-methoxyestradiol.
    Zhou X; Jiang H; Hou J
    Leuk Res; 2007 Sep; 31(9):1259-65. PubMed ID: 17257674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigation of the effect of 2-methoxyestradiol and arsenic trioxide on the apoptosis-associated gene expression profile of myeloma cells].
    Xiong H; Hou J; Gao WR; Chen QB
    Zhonghua Xue Ye Xue Za Zhi; 2005 Apr; 26(4):200-4. PubMed ID: 15949259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of low-dose 2-methoxyestradiol on the expressions of two isoforms of PRDM1 gene in myeloma].
    Jiang H; Hou J
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):38-41. PubMed ID: 19563034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple myeloma cells undergo differentiation upon exposure to rosiglitazone and all-trans retinoic acid.
    Huang H; Wu D; Fu J; Chen G
    Leuk Lymphoma; 2009 Jun; 50(6):966-73. PubMed ID: 19373597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-methoxyestradiol inhibits the anaphase-promoting complex and protein translation in human breast cancer cells.
    Bhati R; Gökmen-Polar Y; Sledge GW; Fan C; Nakshatri H; Ketelsen D; Borchers CH; Dial MJ; Patterson C; Klauber-DeMore N
    Cancer Res; 2007 Jan; 67(2):702-8. PubMed ID: 17234781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differentiating effect of PPARgamma ligand rosiglitazone and all trans-retinoic acid on myeloma cells and its possible mechanism].
    Huang HW; Chen GH; Chang HR; Chow HC; Leung AY; Liang R; Wu DP
    Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):885-9. PubMed ID: 20193324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Methoxyestradiol overcomes drug resistance in multiple myeloma cells.
    Chauhan D; Catley L; Hideshima T; Li G; Leblanc R; Gupta D; Sattler M; Richardson P; Schlossman RL; Podar K; Weller E; Munshi N; Anderson KC
    Blood; 2002 Sep; 100(6):2187-94. PubMed ID: 12200384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism study on low dose tunicamycin inducing myeloma cells differentiation via unfolded protein response].
    Zou JF; Jiang H; Hou J
    Zhonghua Xue Ye Xue Za Zhi; 2010 Oct; 31(10):675-9. PubMed ID: 21223718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel therapy with 2-methoxyestradiol for the treatment of relapsed and plateau phase multiple myeloma.
    Rajkumar SV; Richardson PG; Lacy MQ; Dispenzieri A; Greipp PR; Witzig TE; Schlossman R; Sidor CF; Anderson KC; Gertz MA
    Clin Cancer Res; 2007 Oct; 13(20):6162-7. PubMed ID: 17947482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of genes regulated by 2-methoxyestradiol (2ME2) in multiple myeloma cells using oligonucleotide arrays.
    Chauhan D; Li G; Auclair D; Hideshima T; Richardson P; Podar K; Mitsiades N; Mitsiades C; Li C; Kim RS; Munshi N; Chen LB; Wong W; Anderson KC
    Blood; 2003 May; 101(9):3606-14. PubMed ID: 12480690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Methoxyestradiol induces endoreduplication through the induction of mitochondrial oxidative stress and the activation of MAPK signaling pathways.
    Ting CM; Lee YM; Wong CK; Wong AS; Lung HL; Lung ML; Lo KW; Wong RN; Mak NK
    Biochem Pharmacol; 2010 Mar; 79(6):825-41. PubMed ID: 19883629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class I beta-tubulin mutations in 2-methoxyestradiol-resistant acute lymphoblastic leukemia cells: implications for drug-target interactions.
    Liaw TY; Salam NK; McKay MJ; Cunningham AM; Hibbs DE; Kavallaris M
    Mol Cancer Ther; 2008 Oct; 7(10):3150-9. PubMed ID: 18852118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.